anti-Lidocaine antibody product blog
Tags: Antibody; Monoclonal Antibody; Lidocaine; anti-Lidocaine antibody;
The Lidocaine n/a (Catalog #MBS190309) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Lidocaine can be used in a range of immunoassay formats including, but not limited to, Immunoassay.These anitbodies have been qualified for use in ELISA to detect the assay system. Researchers should empirically determine the suitability of the Lidocaine n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the Lidocaine Monoclonal Antibody with the following immunoassay(s):
Lidocaine (Lidocaine, also known as xylocaine and lignocaine, is a medication used to numb tissue in a specific area. The efficacy of lidocaine as a local anesthetic is characterized by a rapid onset of action and intermediate duration of efficacy. Lidocaine is also the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias. Lidocaine was discovered in 1946 and is on the WHO Model List of Essential Medicines.)
Antigen: Lidocaine conjugated to KLH. Dilutions Instructions: Dilute in PBS or medium which is identical to that used in the assay system.
Appearance: Clear Liquid. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Lidocaine are readily searchable from our website. Different antibodies against the same target such as Lidocaine may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.